Immupharma (25I.STU) Q3 2026 Earnings

24SepConfirmed
Q3 2021
Next
-0.02
0.32
0.65
0.98

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Immupharma (25I.STU) will report earnings of for Q3 2026 on September 24, 2026.

0 Comments

Share your thoughts